Dr Elliott Vichinsky on Jadenu
>> YOUR LINK HERE: ___ http://youtube.com/watch?v=CF40amDnjXI
Novartis announced today that the US Food and Drug Administration (FDA) has approved Jadenu™ (deferasirox) tablets, a new oral formulation of Exjade® (deferasirox) tablets for oral suspension, for the treatment of chronic iron overload due to blood transfusions in patients 2 years of age and older, and chronic iron overload in non-transfusion-dependent thalassemia syndromes (NTDT) in patients 10 years of age and older. Jadenu is the only once-daily oral iron chelator that can be swallowed whole. • To view the Multimedia News Release, go to http://www.multivu.com/players/Englis...
#############################
